RENAL DENERVATION TREATMENT FOR UNCONTROLLED HYPERTENSION | INNOVATIVE TECHNOLOGY UPDATE

Sunday, March 8, 2026

8:00 AM - 9:10 AM EST

Location: International Ballroom West

Moderator(s)

Michael J. Bloch, MD

Medical Director, Vascular Care
Renown Institute for Heart and Vascular Health
reno, Nevada, United States

Disclosure(s): Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
David E. Kandzari, MD, FACC, FSCAI

Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States

Disclosure information not submitted.
Jie Wang, MD, PhD

Professor
Jiangsu Province Hospital
Nanjing, Jiangsu, China (People's Republic)

Disclosure(s): SyMap Medical Ltd: Consulting Fees (e.g., advisory boards) (Ongoing), Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)

Disclosure(s):

Michael J. Bloch, MD: Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jie Wang, MD, PhD: SyMap Medical Ltd: Consulting Fees (e.g., advisory boards) (Ongoing), Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)